Ora Biomedical Aims to Accelerate Longevity Intervention Research with the Million Molecule Challenge
Mitchell Lee, CEO of Ora Biomedical, is revolutionizing longevity research with high-throughput screening in C. elegans, aiming to screen over 1 million compounds in
